Skip to content
Back to EXEL

Exelixis, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
29
Purchases
1
Sales
28
Purchase value
$1.19M
Sale value
$34.80M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Mary C BeckerleDirector
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 10, 20260000939767-26-000101
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 10, 2026
Common StockF1F2F39,812$53.66$526.51K16,079Direct
Filing footnotes · 3
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
  2. F2Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. F3Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Open on SEC EDGAR
Jack L WyszomierskiDirector
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260000939767-26-000085
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F23,925$50.55$198.41K284,384Direct
Filing footnotes · 2
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
  2. F2Includes 8,367 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Open on SEC EDGAR
Sue Gail EckhardtDirector
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260000939767-26-000084
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F2F39,812$50.14$491.97K16,079Direct
Filing footnotes · 3
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.
  2. F2Represents the weighted average sales price. The shares of Exelixis, Inc. common Stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.73 to $50.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. F3Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Open on SEC EDGAR
Dana AftabEVP, Research and Development
4
Filed May 28, 2026Period of report May 26, 20260000939767-26-000070
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 26, 2026
Common StockF143,451$50.35$2.19M594,741Direct
Filing footnotes · 2
  1. F1Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  2. F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 26, 2026.
Open on SEC EDGAR
Patrick J. HaleyEVP, Commercial
4
Filed May 22, 2026Period of report May 20, 20260000939767-26-000069
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 20, 2026
Common StockF1F232,110$49.81$1.60M357,638Direct
Filing footnotes · 2
  1. F1Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $49.80 to $49.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. F2Includes 356,992 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
Open on SEC EDGAR
Christopher J. SennerEVP and CFO
4
Filed May 19, 2026Period of report May 15, 20260000939767-26-000067
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common StockF3F234,901$50.00$1.75M952,317Direct
Filing footnotes · 4
  1. F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025.
  2. F2Includes 403,915 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  3. F3Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $50.00 to $50.07. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  4. F4Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
Open on SEC EDGAR
Brenda HeftiSVP and General Counsel
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 15, 20260000939767-26-000065
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common StockF3F4F26,625$50.21$332.64K106,762Direct
Filing footnotes · 5
  1. F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, February 29, 2024, and February 26, 2025.
  2. F2Includes 106,039 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs, the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs") and 167 shares of Common Stock acquired on April 30, 2026, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  3. F3The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
  4. F4Represents the weighted average sales price. The shares of Common Stock were sold in multiple transactions at prices ranging from $49.84 to $50.51. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
  5. F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
Open on SEC EDGAR
Mary C BeckerleDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000063
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common StockF17,712$48.45$373.65K17,524Direct
Filing footnotes · 2
  1. F1Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  2. F2The option, representing the right to purchase a total of 30,848 shares of Common Stock, became fully exercisable on January 5, 2024.
Open on SEC EDGAR
Maria C FreireDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000062
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common StockF120,634$46.00$949.16K100,819Direct
Filing footnotes · 2
  1. F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  2. F2The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
Open on SEC EDGAR
George PosteDirector
4
Filed May 8, 2026Period of report May 7, 20260000939767-26-000061
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 7, 2026
Common StockF1F260,000$45.71$2.74M118,832Direct
Filing footnotes · 2
  1. F1Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $45.65 to $45.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. F2Includes 9,812 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Open on SEC EDGAR
Dana AftabEVP, Research and Development
4
Filed Feb 26, 2026Period of report Feb 24, 20260000939767-26-000032
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 24, 2026
Common StockF147,918$44.50$2.13M616,106Direct
Filing footnotes · 2
  1. F1Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  2. F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 23, 2026.
Open on SEC EDGAR
Dana AftabEVP, Research and Development
4
Filed Feb 23, 2026Period of report Feb 19, 20260000939767-26-000031
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 19, 2026
Common StockF129,873$44.35$1.32M664,024Direct
Filing footnotes · 2
  1. F1Includes 414,043 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  2. F2Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 18, 2026.
Open on SEC EDGAR
Jack L WyszomierskiDirector
4Rule 10b5-1 plan disclosed
Filed Feb 20, 2026Period of report Feb 18, 20260000939767-26-000030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF2F3F199,574$44.01$4.38M279,942Direct
Filing footnotes · 4
  1. F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  2. F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
  3. F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  4. F4The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
Open on SEC EDGAR
Julie SmithDirector
4
Filed Feb 19, 2026Period of report Feb 17, 20260000939767-26-000029
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF144,087$44.50$1.96M20,590Direct
SaleFeb 18, 2026
Common StockF120,030$44.30$887.33K20,590Direct
SaleFeb 17, 2026
Common StockF2F142,422$43.33$1.84M20,590Direct
Filing footnotes · 5
  1. F1Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  2. F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. F3The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.
  4. F4The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023.
  5. F5The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024.
Open on SEC EDGAR
Brenda HeftiSVP and General Counsel
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260000939767-26-000022
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 18, 2026
Common StockF3F4F218,669$44.01$821.62K96,512Direct
Filing footnotes · 5
  1. F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
  2. F2Includes 95,956 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  3. F3The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.
  4. F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.32 to $44.49. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
  5. F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.
Open on SEC EDGAR
Christopher J. SennerEVP and CFO
4
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000028
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF4F230,617$43.67$1.34M976,092Direct
SaleFeb 13, 2026
Common StockF1F234,278$43.00$1.47M1,042,579Direct
Filing footnotes · 5
  1. F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.04. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. F2Includes 427,690 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  3. F3Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
  4. F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.66 to $43.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
  5. F5Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 13, 2026.
Open on SEC EDGAR
Patrick J. HaleyEVP, Commercial
4
Filed Feb 18, 2026Period of report Feb 15, 20260000939767-26-000027
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF3F23,036$43.84$133.10K446,686Direct
SaleFeb 17, 2026
Common StockF4F264,778$43.50$2.82M381,908Direct
Filing footnotes · 4
  1. F1Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on March 4, 2022, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on January 16, 2025.
  2. F2Includes 381,908 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and PSUs granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
  3. F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.80 to $43.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  4. F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
Open on SEC EDGAR
Sue Gail EckhardtDirector
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000025
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common StockF1F2F33,856$43.79$168.85K17,524Direct
Filing footnotes · 3
  1. F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2025.
  2. F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.89 to $43.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. F3Includes 17,524 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
Open on SEC EDGAR
Bob OliverDirector
4
Filed Feb 18, 2026Period of report Feb 13, 20260000939767-26-000023
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 13, 2026
Common StockF19,088$43.61$396.33K42,282Direct
SaleFeb 13, 2026
Common StockF2F121,162$43.90$929.01K21,120Direct
Filing footnotes · 3
  1. F1Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  2. F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. F3The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.
Open on SEC EDGAR
Partners LP CaliganDirector · See Remarks
David Edward JohnsonDirector
4
Filed Nov 26, 2025Period of report Nov 25, 20250000902664-25-005164
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 25, 2025
Common StockF127,532$43.122$1.19M1,553,262IndirectSee footnote
Filing footnotes · 2
  1. F1This Form 4 is filed by David Johnson ("Mr. Johnson") and Caligan Partners LP ("Caligan") with respect to the securities held by Caligan Partners Master Fund LP ("Caligan Master Fund"), a Cayman Islands limited partnership, and managed accounts ("Caligan Accounts", together with the Caligan Master Fund, the "Caligan Fund and Accounts") to which Caligan serves as investment manager. Mr. Johnson is the Managing Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
  2. F2Includes 9,088 shares of common stock that will be issued to Mr. Johnson upon vesting of restricted stock units. Mr. Johnson is deemed to hold the securities reported herein for the benefit of the Caligan Fund and Accounts, and may, after vesting, if applicable, transfer the securities directly to the Caligan Fund and Accounts.
Open on SEC EDGAR
Patrick J. HaleyEVP, Commercial
4
Filed Nov 24, 2025Period of report Nov 20, 20250000939767-25-000140
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 21, 2025
Common StockF5F228,043$42.58$1.19M374,029Direct
SaleNov 20, 2025
Common StockF1F210,000$42.11$421.10K402,072Direct
SaleNov 20, 2025
Common StockF323,539$41.93$986.99K0IndirectBy spouse
SaleNov 20, 2025
Common StockF410,648$41.77$444.77K0IndirectBy 401(k)
Filing footnotes · 5
  1. F1Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.10 to $42.13. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
  2. F2Includes 374,029 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
  3. F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.87 to $41.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  4. F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $41.77 to $41.79. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
  5. F5Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $42.51 to $42.71. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.